n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with ino-8875 in 2 studies
| Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (ino-8875) | Trials (ino-8875) | Recent Studies (post-2010) (ino-8875) |
|---|---|---|---|---|---|
| 214 | 5 | 58 | 8 | 1 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donegan, RK; Lieberman, RL | 1 |
| Cheng, KJ; Hsieh, CM; Liou, JP; Nepali, K | 1 |
2 review(s) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and ino-8875
| Article | Year |
|---|---|
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Drug Discovery; Glaucoma; Humans; Ligands; Protein Kinase Inhibitors; rho-Associated Kinases; Sympathomimetics | 2016 |
Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye.
Topics: Administration, Ophthalmic; Drug Delivery Systems; Drug Design; Eye Diseases; Genetic Therapy; Humans; Regeneration; Structure-Activity Relationship | 2020 |